Saturday 17 October 2026
Export HITI’s income statement to Excel — free account
High Tide Inc.
HITI Healthcare Pharmaceutical Retailers
High Tide Inc.’s revenue for fiscal 2025 (year ended October 2025) was $424.0 million, up 10.5% from fiscal 2024. In the quarter to July 2026, revenue grew 30.7%, EPS grew 800.0%, free cash flow fell 7.91% and total debt rose 54.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
2.57
0.01
+0.39%
Follow HITI
| Oct '25 | Oct '24 | Oct '23 | Oct '22 | Oct '21 | Oct '20 | Oct '19 | Oct '18 | Oct '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 6 | 6 | 4 | 4 | 6 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.60 | 0.58 | 0.30 | 0.33 | 1.70 | 0.51 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
1.52 | 2.94 | 1.20 | 0.22 | 1.90 | 6.36 | 12.29 | — | — |
P/FCF ratio |
26.38 | 11.47 | 9.97 | 0.00 | 0.00 | 4.40 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(1.57) | (0.47) | (2.37) | (2.16) | 0.24 | (2.08) | (4.79) | 7.51 | — |
P/Operating CF |
91.81 | 31.13 | 15.27 | 14.26 | 59.36 | 53.15 | (50.14) | (50.14) | (50.14) |
Beneish M-Score |
(3.01) | (3.72) | (3.77) | (3.23) | (1.49) | (2.39) | (4.21) | — | — |
P/B ratio |
3.48 | 2.10 | 1.09 | 0.73 | 2.03 | 4.08 | 79.07 | 79.07 | 79.07 |
Dividend Safety Score |
25 | — | — | — | — | — | — | — | — |
Price to Tangible BV |
0.00 | 5.79 | 4.82 | 7.13 | 31.71 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.69 | 0.59 | 0.37 | 0.43 | 1.86 | 0.99 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
41.43 | 10.17 | 0.00 | 0.00 | 44.28 | 3.50 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
17.12 | 8.70 | 8.73 | 34.47 | (119.51) | 8.58 | 0.00 | 0.00 | 0.00 |
EV/FCF |
30.10 | 11.61 | 12.37 | (33.98) | (30.46) | 8.58 | 0.00 | 0.00 | 0.00 |
Quick Ratio |
0.54 | 0.83 | 0.65 | 0.56 | 0.54 | 0.38 | 0.30 | 3.52 | 0.32 |
Current Ratio |
1.37 | 1.40 | 1.18 | 1.07 | 1.13 | 0.70 | 1.18 | 6.76 | 0.50 |
Net Debt/EBITDA |
5.13 | 0.13 | (4.03) | (0.88) | 3.83 | 4.64 | (1.06) | 2.33 | 15.03 |
Debt/Assets |
28.22% | 21.05% | 27.93% | 22.66% | 17.91% | 61.35% | 50.16% | 0.09% | 0.00% |
Debt/Equity |
0.96 | 0.36 | 0.49 | 0.38 | 0.29 | 3.65 | 2.17 | 0.00 | (1.93) |
Asset Turnover |
1.97 | 2.17 | 1.87 | 1.35 | 1.16 | 1.50 | 0.93 | 0.68 | 0.55 |
Operating CF/Net income |
(0.47) | (8.20) | (0.53) | (0.06) | 0.08 | (1.39) | 0.56 | 1.94 | 3.51 |
Capex/Depreciation |
(0.42) | (0.35) | (0.19) | (0.30) | (0.35) | (0.41) | (7.43) | 0.00 | 0.00 |
Interest Coverage |
(1.12) | 0.50 | (4.26) | (6.97) | (1.22) | 0.08 | (6.43) | (48.73) | 0.00 |
| (40.19%) | (3.09%) | (25.91%) | (45.18%) | (43.00%) | (59.84%) | (158.98%) | (66.85%) | 4.45% | |
| (16.85%) | (1.80%) | (15.08%) | (27.24%) | (22.49%) | (11.45%) | (78.43%) | (34.87%) | 1.62% | |
ROIC |
(5.89%) | 2.09% | (15.36%) | (22.71%) | (5.50%) | 1.06% | (42.85%) | 0.00% | 0.00% |
Return on Tangible Assets |
(76.42%) | (8.38%) | (104.41%) | (201.55%) | (115.80%) | (129.62%) | (183.59%) | (24.41%) | (2.91%) |
Average Days of Receivables |
3.45 | 2.31 | 5.67 | 8.39 | 14.46 | 12.54 | 27.82 | 38.28 | 179.34 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
17.73% | 18.01% | 19.04% | 24.09% | 28.29% | 24.13% | 73.50% | 42.06% | 35.84% |
Intangible Assets out of Total Assets |
0.37 | 0.38 | 0.44 | 0.53 | 0.58 | 0.26 | 0.30 | 0.04 | 0.00 |
Share Based Compensation of Revenue |
0.66% | 0.57% | 1.03% | 2.26% | 2.69% | 0.15% | 7.06% | 0.00% | 0.00% |
Graham Net Nets |
(0.31) | (0.05) | (0.21) | (0.41) | (0.16) | (0.93) | (0.02) | (0.02) | (0.02) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(11.90%) | (1.15%) | (25.92%) | (60.96%) | (2.51%) | (7.07%) | (5.13%) | (5.13%) | (5.13%) |
Free Cash Flow Yield |
3.79% | 8.72% | 10.03% | (3.86%) | (3.59%) | 22.70% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
5.16 | 4.82 | 4.86 | 4.42 | 3.39 | 0.27 | 0.12 | 0.53 | 0.62 |
Operating CF per Share |
0.21 | 0.33 | 0.21 | 0.06 | (0.05) | 0.03 | (0.06) | (0.53) | 0.06 |
Capex per Share |
(0.09) | (0.08) | (0.06) | (0.11) | (0.15) | (0.01) | (0.04) | 0.00 | 0.00 |
Free Cash Flow per Share |
0.12 | 0.25 | 0.15 | (0.06) | (0.21) | 0.02 | (0.10) | (0.53) | 0.06 |
Cash per Share |
0.42 | 0.44 | 0.30 | 0.31 | 0.28 | 0.02 | 0.00 | 0.50 | 0.11 |
Shareholders Equity per Share |
0.89 | 1.34 | 1.33 | 2.01 | 2.85 | 0.04 | 0.04 | 1.42 | (0.60) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.89 | 1.34 | 1.33 | 2.01 | 2.85 | 0.04 | 0.04 | 1.42 | (0.60) |
Free Cash Flow |
9.69 | 19.56 | 10.81 | (3.54) | (8.81) | 4.52 | (18.99) | (6.70) | 0.81 |
Working Capital |
26.39 | 17.86 | 7.79 | 3.20 | 4.37 | (6.09) | 1.46 | 11.39 | (7.98) |
Capital Expenditures |
(7.35) | (6.55) | (4.51) | (7.03) | (6.57) | (2.06) | (7.83) | (3.23) | (0.04) |
Net Current Asset Value |
(78.09) | (10.95) | (23.05) | (37.79) | (38.11) | (28.87) | (13.99) | 11.38 | (8.00) |
EV/EBIT |
0.00 | 61.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.03 | 0.05 | 0.03 | 0.33 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 61.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.83 | 0.92 | 1.21 | 0.96 | 0.95 | 0.52 | 0.11 | 0.02 | 0.28 |
Cash ROIC |
5.45% | 10.85% | 6.36% | (1.83%) | (5.25%) | 9.79% | (82.21%) | (27.83%) | 9.65% |
Accounts Receivable Turnover |
131.71 | 95.40 | 60.34 | 45.91 | 36.77 | 31.58 | 18.88 | 2.96 | 3.44 |
Accounts Payable Turnover |
12.28 | 16.92 | 14.52 | 11.16 | 9.55 | 9.65 | 7.26 | 9.77 | 6.09 |
Inventory Turnover |
9.03 | 13.67 | 14.11 | 12.53 | 10.47 | 8.39 | 3.90 | 2.45 | 1.53 |
Average Days of Payables |
39.16 | 22.88 | 21.41 | 38.35 | 57.74 | 44.68 | 80.43 | 45.82 | 46.39 |
Days of Inventory on Hand |
55.86 | 28.19 | 26.60 | 33.40 | 53.10 | 39.68 | 122.76 | 145.91 | 243.34 |
Average Receivables |
3.22 | 4.02 | 5.99 | 6.04 | 3.92 | 1.96 | 1.25 | 2.25 | 2.25 |
Average Payables |
25.61 | 16.49 | 18.19 | 17.81 | 9.76 | 4.04 | 2.07 | 0.68 | 0.68 |
Average Inventory |
34.84 | 20.41 | 18.72 | 15.87 | 8.90 | 4.65 | 3.85 | 2.69 | 2.69 |
Average Assets |
215.04 | 176.97 | 193.23 | 204.62 | 123.87 | 41.29 | 25.22 | 9.89 | 14.20 |
Average Common Equity |
90.14 | 103.00 | 112.48 | 123.38 | 64.80 | 7.90 | 12.44 | 5.16 | 5.16 |
Columns are period end dates · fundamentals updated 2 Oct 2026